tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Vor Biopharma, Inc. (VOR)
:VOR
US Market
VOR
Vor Biopharma
RESEARCH TOOLSreports
Advertisement

Vor Biopharma (VOR) Stock News & Sentiment

Compare
929 Followers
Vor Biopharma Announces $93.7 Million Public Offering
Premium
Company Announcements
Vor Biopharma Announces $93.7 Million Public Offering
5d ago
8K
VOR
Vor Biopharma Appoints New Chief Medical Officer
Premium
Company Announcements
Vor Biopharma Appoints New Chief Medical Officer
14d ago
8K
VOR
Vor Biopharma Unveils Promising Phase 3 Trial Results
Premium
Company Announcements
Vor Biopharma Unveils Promising Phase 3 Trial Results
20d ago
8K
VOR
Major Moves: Fifth Third, HEICO, Transdigm, Cytokinetics, Vor Biopharma
Premium
Weekend Updates
Major Moves: Fifth Third, HEICO, Transdigm, Cytokinetics, Vor Biopharma
23d ago
HEI
TDG
Vor Biopharma’s Strategic Moves and Telitacicept’s Potential Drive Buy Rating Amid Stock Decline
Premium
Ratings
Vor Biopharma’s Strategic Moves and Telitacicept’s Potential Drive Buy Rating Amid Stock Decline
2M ago
VOR
Vor Biopharma Announces 1-for-20 Reverse Stock Split
Premium
Company Announcements
Vor Biopharma Announces 1-for-20 Reverse Stock Split
2M ago
8K
VOR
Vor Biopharma Focuses on Telitacicept Development Strategy
Premium
Company Announcements
Vor Biopharma Focuses on Telitacicept Development Strategy
3M ago
8K
VOR
More VOR News >

VOR News on the Web

Telitacicept Shows Consistent Late-Stage Success Across Multiple Autoimmune Diseases: Vor Bio Reports Q3 2025 Results
Market Chameleon
Neutral
Vor Bio Launches $100 Million Public Offering—A Strategic Step to Advance Phase 3 Clinical Trials
Market Chameleon
Neutral
Vor Biopharma Prices Public Offering Of 10 Mln Shares At $10.00/shr
rttnews
Neutral
Why Vor Biopharma Inc.’s (VOR) Stock Is Down 49.15%
AAII
Neutral
Why Vor Biopharma Inc.’s (VOR) Stock Is Down 5.85%
AAII
Neutral
Why Vor Biopharma Inc.’s (VOR) Stock Is Down 9.68%
AAII
Neutral
Vor Biopharma Appoints Jeremy Sokolove As New Chief Medical Officer
rttnews
Neutral
Why Vor Biopharma Inc.’s (VOR) Stock Is Down 5.18%
AAII
Neutral

News Score - Last 7 Days

Neutral
VOR
Sector Average
Media Buzz
This Week2 articles
Weekly Average3.25 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VOR’s Media Buzz Sentiment?
2 articles about VOR were published this week. In an average week, 3.25 articles are published.
    What is VOR’s weekly average amount of articles?
    In an average week, 3.25 articles about VOR are published.
      What is VOR’s News Sentiment?
      50% of articles about VOR were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        ELMDElectromed
        0RJTRedcare Pharmacy
        KRMDREPRO-MED Systems
        0O9BAlmirall
        ADMAADMA Biologics
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing